- Home
- APDN vs ONCO Comparison
APDN vs ONCO Comparison
Compare APDN & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APDN
- ONCO
- Stock Information
- Founded
- APDN 1983
- ONCO 2018
- Country
- APDN United States
- ONCO United States
- Employees
- APDN N/A
- ONCO N/A
- Industry
- APDN Other Consumer Services
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- APDN Consumer Discretionary
- ONCO Health Care
- Exchange
- APDN Nasdaq
- ONCO Nasdaq
- Market Cap
- APDN 1.7M
- ONCO 1.8M
- IPO Year
- APDN N/A
- ONCO 2022
- Fundamental
- Price
- APDN $2.98
- ONCO $2.93
- Analyst Decision
- APDN
- ONCO
- Analyst Count
- APDN 0
- ONCO 0
- Target Price
- APDN N/A
- ONCO N/A
- AVG Volume (30 Days)
- APDN 79.6K
- ONCO 106.4K
- Earning Date
- APDN 08-26-2025
- ONCO 08-14-2025
- Dividend Yield
- APDN N/A
- ONCO N/A
- EPS Growth
- APDN N/A
- ONCO N/A
- EPS
- APDN 211.51
- ONCO N/A
- Revenue
- APDN $3,743,063.00
- ONCO $1,326,959.00
- Revenue This Year
- APDN $57.08
- ONCO N/A
- Revenue Next Year
- APDN $40.00
- ONCO N/A
- P/E Ratio
- APDN $0.02
- ONCO N/A
- Revenue Growth
- APDN 55.60
- ONCO N/A
- 52 Week Low
- APDN $3.00
- ONCO $2.61
- 52 Week High
- APDN $1,410.00
- ONCO $552.50
- Technical
- Relative Strength Index (RSI)
- APDN 27.16
- ONCO 42.52
- Support Level
- APDN $3.20
- ONCO $2.94
- Resistance Level
- APDN $3.64
- ONCO $3.20
- Average True Range (ATR)
- APDN 0.25
- ONCO 0.20
- MACD
- APDN -0.02
- ONCO 0.07
- Stochastic Oscillator
- APDN 1.60
- ONCO 52.54
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.